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using modiﬁed clays
Saleh Sulaimana,b, Mustafa Khamisc,d, Shlomo Nire, Filomena Lelarioa, Laura Scranof , Sabino Aurelio Bufoa and
Raﬁk Karamana,b∗
aDepartment of Science, University of Basilicata, Potenza 85100, Italy; bDepartment of Bioorganic Chemistry, Faculty of Pharmacy,
Al-Quds University, Jerusalem 20002, Palestine; cDepartment of Chemistry and Chemical Technology, Faculty of Science and
Technology, Al-Quds University, Jerusalem 20002, Palestine; dDepartment of Biology, Chemistry and Environmental Sciences,
American University of Sharjah, POB 26666, Sharjah, United Arab Emirates; eDepartment of Soil and Water Sciences, Faculty of
Agriculture, Food and Environment, Hebrew University of Jerusalem, Rehovot 76100, Israel; f Department of Mediterranean Culture,
University of Basilicata, Matera 75100, Italy
(Received 7 July 2013; accepted 20 January 2014 )
Stability and removal of dexamethasone sodium phosphate (DSP) from wastewater produced at Al-Quds University Campus
were investigated. Kinetic studies in both pure water and wastewater coming from secondary treatment (activated sludge)
demonstrated that the anti-inﬂammatory DSP underwent degradation to its hydrolytic derivative, dexamethasone, in both
media. The ﬁrst-order hydrolysis rate of DSP in activated sludge at 25◦C (3.80 × 10−6 s−1) was about 12-fold larger than in
pure water (3.25 × 10−7 s−1). The overall performance of the wastewater treatment plant (WWTP) installed in the University
Campus was also assessed showing that 90% of spiked DSP was removed together with its newly identiﬁed metabolites by
the ultra-ﬁltration (UF) system, which consists of a UF hollow ﬁbre (HF) with a 100-kDa cutoﬀ membrane as the pre-
polishing stage for the UF spiral wound with a 20-kDa cutoﬀ membrane. In testing other technologies, the eﬀectiveness of
adsorption and ﬁltration by micelle–clay (MC) preparation for removing DSP was ascertained in comparison with activated
charcoal. Batch adsorption in aqueous suspensions of theMCcomposite and activated carbonwaswell described byLangmuir
isotherms showing the best results for MC material. Filtration of DSP water solutions demonstrated a signiﬁcant advantage
of columns ﬁlled in with a mixture of sand and MC complex in comparison with activated carbon/sand ﬁlters.
Keywords: dexamethasone sodium phosphate; wastewater treatment; activated sludge; activated charcoal; micelle–clay
complex; column ﬁltration
Nomenclature
DSP dexamethasone sodium phosphate
FAC ﬁne powder activated charcoal
GAC granular activated charcoal
HF hollow ﬁbre UF membrane
HP hydrolysis product
MC micelle–clay complex
ODTMA octadecyl trimethyl ammonium
RO reverse osmosis
SW spiral wound UF membrane
UF ultra-ﬁltration
WWTP wastewater treatment plant
1. Introduction
Despite the progress in water treatment methods, vary-
ing amounts of chemicals exist in what is referred to as
‘clean’ water.[1] Organic contaminants in the environment,
especially in water, have become a major concern due to
their toxicity. To remediate this pollution problem, various
∗Corresponding author. Email: dr_karaman@yahoo.com
chemical, physical and biological processes have been
developed, such asmicrobial degradation, ﬁltration, adsorp-
tion, coagulation and membrane separation. However, all
these remediation methods have suﬀered from certain lim-
itations and disadvantages such as high cost, poor removal
eﬃciency and possibility of desorption.[1] This is an ever
growing problem including the so-called ‘emerging pollu-
tants’, which comprise a large number of pharmaceuticals.
For the past three decades, data have been accumulated on
the concentrations of pharmaceutical residues in drinking
water.[2]
The occurrence of pharmaceutically active substances
in the environment has become an important issue in the
last few years. These compounds along with their metabo-
lites, which can be even more harmful than the original
compounds, are continuously released into the environ-
ment, mainly through disposal of unused or expired drugs
or directly from pharmaceutical discharges.[3]
Pharmaceuticals are generally excreted after being par-
tially or completely converted tometabolites with enhanced
© 2014 Taylor & Francis
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Figure 1. Flow diagram schematizing the WWTP at Al-Quds
University. Sampling sites are indicated by numbers. UF/HF,
hollow ﬁbre ultra-ﬁltration membrane; UF/SW, spiral wound
ultra-ﬁltration membrane; RO, reverse osmosis; GAC, granular
activated charcoal ﬁlter.
solubility in water, but a signiﬁcant quantity of the par-
ent drug may also be excreted unchanged.[4] Most of
these compounds come either from domestic sewage or
fromhospitals, or industrial discharges, and entermunicipal
wastewater treatment plants (WWTPs). The removal eﬃ-
ciency of WWTPs is inﬂuenced by the chemical properties
of each speciﬁc compound to be removed, microbial activ-
ity in the activated sludge (AS) unit, use of membrane units
and environmental conditions realized in the plant.[5–7]
Recent studies have clearly shown that the elimina-
tion of pharmaceutically active compounds in munic-
ipal WWTPs is often incomplete,[8] with eﬃciencies
ranging between 60% and 90% for a variety of polar
compounds.[9–12]
To evaluate the eﬃciency of diﬀerent traditional and
innovative tools for the elimination of pharmaceutical
residues, we are performing a series of water puriﬁca-
tion experiments by using the WWTP installed at the
Al-Quds University in Palestine (Figure 1), which includes
sequential units, such as AS, ultra-ﬁltration (UF), granular
activated charcoal (GAC) and reverse osmosis (RO).[4]
Problems arising from the management of such a plant
can be referred to the capability of the AS unit to favour the
bio-degradation of organic pollutants as well as the fouling
phenomenonaﬀectingmembraneunits,whichmust beoften
replaced with high costs.
In the presentwork,we are reporting about the eﬃciency
of advanced wastewater treatment technologies adopted
in the Al-Quds plant for the removal of ‘dexamethasone
sodium phosphate’ (DSP), which was used as the model
pharmaceutical compound due to its high solubility inwater
and large consumption in many Countries. Nevertheless,
because of the tendency of DSP to undergo hydrolysis in a
large range of pH, wewere also concernedwith the removal
of its hydrolysis product ‘dexamethasone’.
Aiming at the assessment of bacterial culture, which
normally develops in the AS unit of Al-Quds WWTP, the
stability of DSP in pure water as well as in the AS collected
from the plant was investigated and the DSP degradation
products were identiﬁed.
Finally, to check for diﬀerent tools to be used instead
of UF membranes, the eﬀectiveness of micelle–clay (MC)
ﬁlter for removing DSP was ascertained and compared
with a ﬁlter ﬁlled with GAC. Besides, the DSP adsorption
equilibrium parameters and the adsorption Langmuir coef-
ﬁcients were determined by using bothMC and ﬁne powder
activated charcoal (FAC) as the adsorbent materials.
DSP, 9-ﬂuoro-11β,17-dihydroxy-16α-methyl-21-(pho-
sphonooxy) pregna-1,4-diene-3,20-dione disodium salt
(structure 1 in Scheme 1), a synthetic adrenocortical steroid,
is a white or slightly yellow, crystalline powder. It is highly
soluble inwater and is exceedingly hygroscopic. It is widely
used to treat inﬂammation, allergy and diseases related to
adrenal cortex insuﬃciency. DSP is also known to reduce
neointimal hyperplasia in arteries.[13,14] It is used for coat-
ing drug-eluting stents for local drug delivery to prevent
restenosis [15–17] and is 5–14 timesmore potent than pred-
nisolone and 25–75 times more potent than cortisone and
hydrocortisone.[18] The corticosteroids cause alterations in
metabolism of fats, proteins and carbohydrates, and aﬀect
a range of organs in the body including the heart, mus-
cle and kidneys. Blood chemistry may change and there
is decreased activity and shrinkage of the thymus gland,
adrenal glands, spleen and lymph nodes. The liver becomes
enlarged, thyroid activity decreases and mineral is drawn
away from bone. Muscle wasting occurs, and the immune
system is adversely aﬀected causing the person to be more
susceptible to infections, especially of the eye.[13–17] DSP
is one of the most water-soluble adrenocorticosteroidal
agents. It is, therefore, suitable for intravenous use and
particularly for ophthalamic formulations.[19]
TheMC composite, whichwas used in this study, is pos-
itively charged, has large surface area and includes large
hydrophobic domains.[20] Micelle–clay composites have
already been proven useful in the removal of about 20
neutral and anionic pollutants.[20–25]
2. Experimental
2.1. Materials and equipment
2.1.1. Materials
All chemicals were of analytical grade. The clay used
was Wyoming Na-montmorillonite SWY-2 clay; obtained
from the Source Clays Registry (Clay Mineral Society,
Colombia,MO,USA). Quartz sand (grain size 0.8–1.2mm)
was obtained from Negev industrial minerals (Israel).
Octadecyl trimethyl ammonium (ODTMA) bromide was
obtained from Sigma–Aldrich. Pure DSP and its hydroly-
sis product dexamethasone (structure 2 in Scheme 1) were
obtained from Birzeit Pharmaceutical Company (Pales-
tine) with 99% purity, and both were used as received.
FAC with particle size ≤ 60.0μm, and GAC with parti-
cle size ≤ 700.0μm were obtained from Sigma (Sigma
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Scheme 1. Structures of DSP (1) and its hydrolysis product dexamethasone (2).
Chemical Company, USA). The powder was used for
batch adsorption experiments while the granules were used
in column experiments. Magnesium sulphate anhydrous,
potassium dihydrogen phosphate as well as methanol and
water for analysis (HPLC grade) were purchased from
Sigma–Aldrich (Munich, Germany). High-purity diethyl
ether (>99%) was purchased from Biolab (Israel).
For sample enrichment and puriﬁcation, SPE 1 g C–18
6mL disposable cartridges (Waters, Milford, MA, USA)
were used.
2.1.2. Equipment
Sampleswere shakenusingBigBill, (Banstaed/Themolyne,
USA). The disappearance ofDSP and its hydrolysis product
were determinedbyusing ahigh-pressure liquid chromatog-
raphy system model 2695 HPLC from Waters (Israel),
equipped with a Waters 2996 Photodiode array. Data acqui-
sition and control were carried out using Empower™
software (Waters, Israel). Analytes were separated on a
4.6mm × 150mm C18 XBridge® column (5-μm particle
size) used in conjunction with a 4.6mm, 20μm, XBridge®
C18 guard column.
HPLC conditions: mixture of 0.01M KH2PO4:
methanol (1:1; v/v) as mobile phase; ﬂow rate of
1.2mLmin−1; UV detection at a wavelength of 254 nm
Acrodisc®syringeﬁlterswithGHPmembrane (hydrophilic
polypropylene 0.45-μmporosity) fromWaters were always
used for all analytical ﬁltration requirements. The identiﬁ-
cation of DSP degradation products was performed using
a liquid chromatography system coupled to a hybrid lin-
ear quadrupole ion trap–Fourier-transform ion cyclotron
resonance (FT-ICR) mass spectrometer (Thermo Fisher
Scientiﬁc, Bremen, Germany).
The advanced WWTP employed in this study is located
at Al-Quds University-Palestine andwas described in detail
elsewhere.[24] Normally, the eﬄuent from this plant is
recycled for the irrigation of plants cropped in the ﬁeld of
university campus.
2.2. Methods
Linearity of the proposed analytical method was veriﬁed by
analysing standard solutions in the range of 0.1–100mgL−1
for both DSP and its hydrolysis product in pure water.
The calibration curves were obtained with a determina-
tion coeﬃcient R2 of 0.9996 and 0.9998, respectively.
The repeatability of triplicate subsequent injections was
ranging from 98.8% to 99.5%, depending on the sam-
ple concentration and type of analyte. The repeatability of
morning/evening injections on the basis of 6-hours elapsed
time was ranging from 97.6% and 98.2%, and was also
aﬀected by the concentration and type of analyte. Correction
coeﬃcients were used for experimental samples.
Calibration curves and repeatability trials were repeated
preparing new calibration solutions by using wastewater
taken from the AS reservoir of Al-Quds WWTP. Results
suﬀered from a major inaccuracy due to the variability
of recovery percentages. The determination coeﬃcients of
calibration curves were 0.9985 for DSP and 0.9989 for
dexamethasone. Repeatability normally was not reduced.
The limit of detection, based on a signal/noise of 3, was
0.02mgL−1 for DSP and 0.01mgL−1 for dexamethasone.
The limit of quantiﬁcation, based on a signal/noise of
10, was 0.06 and 0.03mgL−1 for DSP and its hydrolysis
product, respectively.
2.2.1. Characterization of wastewater used
The wastewater was characterized before the experiments
according to American Public Health Association pro-
cedures [26,27] by performing measurements listed in
Table S1 (Supplementary material).
The initial relatively high values of COD and TSS may
be attributed to residues of chemicals in thewastewater from
laboratories, whichwere notwell removed by the secondary
biological treatment.
Table S2 (Supplementary material) summarizes chem-
ical, physical and biological characteristics of wastewater
sampled from the AS reservoir of Al-Quds WWTP (sam-
pling site #2 in Figure 1). This table reveals that the
wastewater contained high amounts of suspended solids
and large populations of bacteria, which are responsible for
the fouling phenomena aﬀecting UF and RO membranes.
Moreover, high values of electrical conductivity and total
dissolved solids are typical for municipal wastewaters and
should be reduced if WWTP eﬄuents are re-used for crop
irrigation purposes.
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2.2.2. Eﬃciency of WWTP for DSP and dexamethasone
removal
The eﬃciency of diﬀerent treatment units was ascer-
tained by spiking separately the secondary eﬄuent with
1.0mgL−1 of either DSP or its hydrolysis product dex-
amethasone in the AS reservoir (1000 L). Samples were
collected from diﬀerent locations of the WWTP as depicted
in Figure 1. Before analysis of DSP, 1mg of KH2PO4 was
added to 100mL of sample to stabilize pH, the acidic form
of DSP and the ionic strength of the solution. SPE-C18 dis-
posable cartridges were used to pre-concentrate 10mL of
each sample by adsorption of analytes. A part (20μL) of the
methanolic solution eluted from SPE cartridge was injected
into the HPLC and analysed using the same conditions for
the determination of both DSP and dexamethasone. Recov-
ery tests were performed using triplicate solutions of both
substances, and values ranging from 98% to 102% were
obtained.
2.2.3. Stability of DSP
Stability study of DSP was performed using 100mgL−1
solutions in pure water, or AS taken from the WWTP
installed at Al-Quds University. Samples at speciﬁc
time intervals (0–14 days) were collected from the
stability solutions (maintained under continuous orbital
shaking), ﬁltered and analysed by HPLC. The degra-
dation by-products of DSP were investigated using
liquid chromatography/Fourier-transform ion cyclotron
resonance/mass spectrometry.
2.2.4. Micelle–clay complex preparation
The ODMTA MC complex was prepared by mixing a
smectitic clay mineral (montmorillonite) with the cationic
surfactant ODTMA (as bromide salt) with a critical micelle
concentration value of 0.3mM as described previously.[21]
The added surfactant was mostly in micellar form. The
obtained complex by virtue of its positive charge and
hydrophobic region is capable of eﬃciently binding neutral
and negatively charged organic molecules.[21–25,28]
2.2.5. Batch adsorption experiments
Batch adsorption experiments were carried out on DSP at
diﬀerent concentrations. Experiments were performed in
250mL Erlenmeyer ﬂasks containing 200mg of either MC
complex or FAC; 100mL of DSP solutions having known
initial concentration was then introduced into each ﬂask.
The ﬂasks were shaken in an oscillating shaker for 3 hours
at room temperature, and then the content of each ﬂask was
centrifuged (10,000 g) for 5min and ﬁltered using 0.45-μm
ﬁlters. The equilibrium concentrations of DSP were then
obtained by HPLC, using the conditions reported above.
The retention time of DSP was 6 min.
2.2.6. Column ﬁltration experiments
Column ﬁltering experiments were performed using 50:1
(w/w) mixtures of quartz sand and either ODTMA–clay
complex, or GAC, 20 cm layered in borosilicate columns
of 25-cm length and 5-cm diameter. Each column con-
tained 13 g of complex, or GAC. The bottom of the column
was covered with 3-cm layer of quartz sand. Quartz sand
was thoroughly washed by distilled water and dried at
105◦C for 24 h before its use. Solutions in pure water (1 L
each) containing diﬀerent DSP concentrations (0.01, 1, 10
and 100mgL−1) were passed through either MC or GAC
columns (one column for each solution). In all cases, the
ﬂow rate was 2.0mLmin−1. Eluted fractionswere collected
in all column experiments and analysed.
All experiments reported in Sections 2.2.1–2.2.6 were
performed in three replicates, and average values and
standard deviations were calculated.
3. Results and discussion
3.1. Eﬃciency of WWTP for DSP and dexamethasone
removal
The eﬃciency of WWTP at Al-Quds University for the
removal of DSP and dexamethasone was studied. The
AS reservoir (site 1 in Figure 1) was separately spiked
with either DSP or dexamethasone at a concentration
of 1.0mgL−1, which is an amount close to literature
ﬁndings.[8,11] Samples were taken from diﬀerent collect-
ing sites of WWTP as described in Section 2.2.2 and
Figure 1. Analytical results of water eﬄuent from UF
system indicated that the eﬃciency of the UF process is
about 63–95% (sample nos 4 and 6, see also Figure 1 and
Table 1).[24,25] DSP was completely removed in the eﬄu-
ent from GAC ﬁlter. However, it should be outlined that the
concentration of DSP (or dexamethasone) inﬂuent in the
treatment units was diminishing along their sequence. This
relationship reﬂected upon 100% removal by GAC ﬁlter,
where inﬂuent water contained only 0.06mgL−1 of DSP,
or 0.07mgL−1 of dexamethasone, on average, after the pas-
sage through the UF ﬁlters. This ﬁnding made unnecessary
the use of RO for any further puriﬁcation. Nevertheless,
the advanced technology adopted in the WWTP of Al-
QudsUniversity did not overcome a problem common to all
plants: the production of brine, in which a large portion of
the contaminants ends up being concentrated there. For this
reason, diﬀerent methods of water ﬁltration and puriﬁcation
should be experimented.
3.2. Stability of DSP in pure water and in sludge
Literature survey on the stability of DSP indicates
that the drug undergoes degradation in aqueous solu-
tions buﬀered at various pH values, temperature, light
exposure and oxidative conditions.[29] Furthermore,
DSP cleaves into four major degradation products.
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Table 1. Removal of DSP and dexamethasone (hydrolysis product – HP) from wastewater by diﬀerent treatment units in Al-Quds
WWTP; average values of three replicates.
Concentration of DSP and dexamethasone (HP) (mgL−1)
Means ± SD Remaining (%)
Sample description Sampling site as in Figure 1 DSP HP DSP HP
AS spiked amount 1 1.0 1.0
UF-HF Inﬂuent 2 0.83 ± 0.05 0.81 ± 0.02
Concentrates produced 3 0.46 ± 0.04 0.43 ± 0.04
Eﬄuent 4 0.31 ± 0.03 0.24 ± 0.02 37.3 29.6
UF-SW Concentrates produced 5 0.19 ± 0.02 0.17 ± 0.02
Eﬄuent 6 0.06 ± 0.03 0.07 ± 0.04 5.3 8.6
GAC eﬄuent 7 b.l.d. b.l.d. ≈0.0 ≈0.0
b.l.d., below the limit of detection.
Figure 2. Chromatogram showing the appearance of an intense
peak attributable to dexamethasone, the hydrolysis product of dex-
amethasone sodium phosphate risen after 2 weeks of incubation
in pure water.
They were identiﬁed as dexamethasone-21-oic acid, 17-
oxodexamethasone, 6β-hydroxy dexamethasone and 16,17-
unsaturated dexamethasone.[30]
Figure 2 illustrates the HPLC chromatogram of DSP
after 2 weeks of incubation in pure water at room tempera-
ture (C(0) = 100mgL−1). The peak at 6-min retention time
is characteristic of the acidic form of DSP, and the peak at
10.3-min can be attributed to its hydrolysis product dexam-
ethasone. The kinetic data of DSP hydrolysis in pure water
are plotted in Figure 3 (plot a) as natural logarithm of DSP
concentration vs. time (days). The determination coeﬃcient
R2 of the ﬁrst-order hydrolysis reaction was 0.9981, and the
kinetic constant was 3.25 10−7 s−1.
Similarly, a kinetic study on the stability of DSP was
conducted in the AS at room temperature. The determina-
tion coeﬃcient R2 in this case was 0.9987 (Figure 3, plot b),
and the kinetic constant was 3.80 × 10−6 s−1. The degrada-
tion half-life was diminished from 24.7 days in pure water
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Figure 3. Kinetics of DSP degradation in pure water (plot a)
and activated sludge (plot b). Data are reported as natural log-
arithm of concentrations (C(t)) vs. time. Initial concentration
(C(0)) = 100mgL−1. Plotted values are the means of three repli-
cates; bars represent the standard deviations calculated for each
average value.
to 2.1 days in the AS, where the concentration of the parent
molecule was found at the level of 1mgL−1 after 2 weeks
of incubation. The degradation rate in the sludge medium
was about 12-fold faster than in pure water. The accelerated
degradation can be attributed to bioactivity of the AS.
Monitoring the derivative substances arising from the
degradation of DSP in the AS showed that the ﬁrst
degradation product, dexamethasone, underwent further
degradation to other by-products as identiﬁed-bymass spec-
trometrical analysis. Extracted ion chromatogram (XIC) of
the 14-day biodegraded sample is shown in Figure 4. Using
very selective XICs by FT-ICR/MS, generated with a tight
mass-to-charge ratio window of ±0.0010 units around each
selected protonated molecule (i.e. [M + H]+ ± 1.0mDa),
greatly reduced the signal complexity of the total ion current
trace (data not shown) allowing to completely characterize
all degradation products.
In addition to dexamethasone, which was formed from
hydrolysis of DSP, seven major biodegradation products
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Figure 4. Extracted ion chromatograms (XICs) acquired by LC/ESI-FTICRMS in positive ion mode for the aqueous sample collected
after 2 weeks of biodegradation from the activated sludge spiked with 100mgL−1 of DSP. The ions monitored are displayed in each trace
and correspond to the most abundant protonated moieties [M+H]+, using a restricted window of ±0.0010 m/z unit centred around each
selected ion (Table S1 in Supplementary material).
were identiﬁed arising from dexamethasone biodegradation
at retention times 8.53 (3), 10.23 (4), 9.68 (5), 10.11 (6),
8.59 (7), 8.59 (8) and 10.48 (9) minutes. Based on the accu-
rate m/z values (Table S1, in Supplementary material) and
relevant literature,[30] we propose the following structures
for all degradation products evolved (Figure 5):
C20H25FO3 [17-oxodexamethasone] (3),
C22H29FO6 [6′-hydroxy dexamethasone] (4),
C20H27FO3 [testosterone] (5),
C22H28O6 [3′,4′-dihydroxy-10,13-dimethylspiro[1,2,6,7,8,
9,12,14,15,16-deca hydro cyclo penta [a] phenanthrene-
17,5′-oxolane]-2′,3,11-trione] (6),
C20H22O2 [(8S,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,14,
15,16,17-octahydro-1H-cyclopenta [a] phenanthren-17-yl]
(7),
C20H24O3 [(8S,13S,14S,17R)-17-ethynyl-17-hydroxy-13-
methyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenan-
thren-3-one] (8),
C22H31O6F [6-Fluoro-11,14,17,21-tetrahydroxy-16-meth-
ylpregn-4-ene-3,20-dione (9).
Figure 6 describes the suggested pathway by which
dexamethasone degrades to metabolites (4) and (9). The
hydroxyl group can attack two diﬀerent positions on the
dexamethasone moiety. Figure 7 illustrates the proposed
pathways for the degradation of (4) to the other degradation
products (3, 6, 7 and 8).
The FT-ICR infrared multiphoton dissociation MS/MS
spectrum, reported in Figure S1 (Supplementary material),
shows that compound (8) gives a molecular peak at m/z
313 and three fragments with m/z 295 [M-H2O + H]+, 277
[M-2H2O + H]+ and 267 [M-H2O − CO + H]+, due to the
loss of H2O and CO. In Figure 7, the ﬁrst pathway (A–B)
leads from compound (4) to compound (3) by the loss of
H2O, formaldehyde andCOmoieties, then to compound (8)
through the loss of hollow ﬁbre (HF). The second pathway
(C–D) leads fromcompound (4) to compound (6) by the loss
of HF molecule, and successively to compound (8) with the
loss of water, formaldehyde and CO groups.
To the best of our knowledge, no publication has
appeared on biodegradation of DSP or dexamethasone in
wastewater. However, there are some in vitro and in vivo
studies in rat and human livers on DSP metabolism to 17-
oxodexamethasone and 6-hydroxy dexamethasone, which
are two of main derivative substances we report in Figure 5
as number (3) and (4), and side chain cleaved metabolites
[30] having a structure diﬀerent from derivatives identiﬁed
in our work.
3.3. Adsorption isotherms
The adsorption of DSP at several initial concentrations
on MC complex and activated charcoal was investigated.
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Figure 5. Chemical structures of dexamethasone biodegradation products. 17-Oxodexamethasone C20H25FO3, exact MW
332.17822 (3); 6-hydroxy dexamethasone C22H29FO6, exact MW 408.19427 (4); testosterone C20H27FO3, exact MW
334.19387 (5); 3′, 4′-dihydroxy-10,13-dimethylspiro[1,2,6,7,8,9,12,14,15,16-deca hydro cyclo penta [a] phenanthrene-17,
5′-oxolane]-2′,3,11-trione C22H28O6, exact MW 388.18804 (6); [(8S,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,14,15,16,
17-octahydro-1H-clopenta[a]phenanthren-17-yl] acetate C20H24O3, exact MW 312.17200 (7); (8S,13S,14S,17R)-17-ethynyl-
17-hydroxy-13-methyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C20H22O2, exact MW 294.16143 (8);
[6-Fluoro-11,14,17, 21-tetrahydroxy-16-methylpregn-4-ene-3,20-dione C22H31O6F, exact MW 410.20992 (9).
Equilibrium relationships between adsorbent and adsorbate
can be described by Langmuir adsorption isotherm,[24,31–
33] represented by the following equation:
Ce
Qe
= 1
(kQmax)
+ Ce
Qmax
(1)
where Ce (mgL−1) is the equilibrium concentration of the
drug in the solution, Qe (mg g−1) is the equilibrium mass of
the adsorbed drug per gram of complex or activated char-
coal, k (Lmg−1) is the Langmuir binding constant andQmax
(mg g−1) is the maximum mass of drug removed per gram
of complex.
The data ﬁtted well the Langmuir equation giving
R2 = 0.9953 for activated charcoal and 0.9997 for the MC
(Figure 8). Langmuir constants Qmax and k were deter-
mined from the slope and intercept in Figure 8. These
values forMCcomplex are 652.1mgg−1 and 2.795 Lmg−1,
respectively, whereas the values for activated charcoal are
103.4mg g−1 and 0.184 Lmg−1, respectively. The Lang-
muir binding constant ‘k’ for the MC complex was about
15-fold greater compared with the activated charcoal, and
the value of Qmax was nearly sixfold higher for the former.
The values of k and Qmax parameters suggest that the MC
complex is a better adsorbent of DSP than the activated
charcoal.
3.4. Modiﬁed clay adsorption
DSP solutions were passed through ﬁlters that included the
MC complex or activated charcoal mixed with excess sand
at 1:50 ratios (w/w). Results (Table 2) indicate a signiﬁcant
advantage of the MC ﬁlter in removing DSP compared with
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Figure 6. Proposed transformation pathway for the biodegradation of dexamethasone sodium phosphate (1).
the removal by activated charcoal. This ﬁnding was not sur-
prising, since parameters obtained for adsorption isotherms
have clearly shown that the MC complex was more eﬃ-
cient than the activated charcoal in adsorbing DSP from
water.
Previous reported experiments demonstrated the advan-
tage of the MC ﬁlters in removing anionic and certain
neutral pollutants.[21–23]
Polubesova et al. [21] found a very eﬃcient removal
from water of neutral and anionic herbicides by micelle–
clay complexes. In another study,[22] column ﬁlters ﬁlled
with a mixture of quartz sand and micelle–clay complex
provided a very eﬃcient result for the retention of tetracy-
cline and sulphonamide pharmaceuticals from wastewater.
Zadaka et al. [23] tested column ﬁlters with either a mix-
ture of quartz sand and organicmicelle –montmorillonite or
zeolite; both ﬁlters were capable of removing well ethylene
dibromide, anionic pollutants as sulphosulphuron, imaza-
quin and sulfentrazone, and neutral compounds such as
bromacil and chlorotoluron from aqueous environments;
in contrast, a ﬁlter ﬁlled with the same weight of activated
carbon and sand only partially removed these pollutants.
In a recent paper, Karaman et al. [24] showed that MC
ﬁltersweremore eﬃcient towards the removal of diclofenac
potassium fromwastewater than activated carbon.Morover,
Khamis et al. [1] concluded that the incorporation of MC
ﬁlters in sewage treatment systems with loose tertiary capa-
bility can be a promising technology. More recently, Khalaf
et al. [25] suggested that the integration of clay–micelle
complex ﬁlters in existing WWTPs may be helpful for
improving the removal eﬃciency of recalcitrant residues
of non-steroid anti-inﬂammatory drugs.
In laboratory study, Qurie et al. [32] found that micelle–
clay complex ﬁlters under continuous naproxen-spiked
water ﬂowing are eﬃcient in removing naproxen, suggest-
ing that the eﬃciency of the existing advanced WWTP
could be improved by including ﬁltration columns ﬁlled
with suitable sand/micelle–clay mixtures.
It can be argued that in addition to DSP residues
wastewater usually includes other recalcitrant organic
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Figure 7. Proposed transformation pathways for dexamethasone (4).
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Table 2. Removal of DSP by ﬁltration of 1 L of pure water
solutions (100, 10, 1.0, 0.01mgL−1) through laboratory ﬁlters,
which included either MC or GAC mixed with excess sand at
1:50 (w/w) ratio; means of three replicates.
Initial concentration Column Average eluted
(mgL−1) typea concentration (mgL−1) ±SD
100 MC b.l.d. –
100 GAC 64.3 1.2
10 MC b.l.d. –
10 GAC 3.1 0.5
1.0 MC b.l.d. –
1.0 GAC 0.17 0.08
0.01 MC b.l.d. –
0.01 GAC b.l.d. –
aFlow rate, 2mLmin−1; temperature, 25◦C; b.l.d., below the
detection limit of the analytical method used.
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pollutants.[33–36] In such cases, GAC ﬁlters can be used as
a ﬁrst-stage tertiary process to remove the majority of neu-
tral pollutants, and additional MC ﬁlters can be adopted as
the second stage to eliminate anionic pollutants, and neutral
compounds not retained by GAC ﬁlters.
4. Conclusions
In this study, we determined the rates of degradation of
DSP in pure water and in sludge. The degradation products,
which were identiﬁed by LC–MS and LC/MS/MS tech-
niques, were found to include not only the already known
metabolites 17-oxodexamethasone and 6′-hydroxy dexam-
ethasone but also many others derivatives not previously
investigated.
The study demonstrated that the advanced treatment
technologies installed at the WWTP of Al-Quds University
were eﬀective for the complete removal of both DSP and
its hydrolysis product from 1mgL−1 spiked wastewater.
The ﬁltration performed using the mixture sand/MC
complex was able to remove and retain very high con-
centrations of DSP from aqueous solutions. The large
eﬀectiveness and removal capacity of the MC complex are
due to the high adsorption aﬃnity towards the anionic DSP
by the relatively large number of positively charged and
hydrophobic sites of the MC complex based on ODTMA.
Funding
This workwas partially supported by a generous grant from Sanoﬁ
Pharmaceutical Company (France)managed through Peres Center
for Peace. S.A.B. and S.N. thank the European Commission in
the framework of the Project ‘Diﬀusion of nanotechnology based
devices for water treatment and recycling – NANOWAT’ [ENPI
CBC MED I-B/2.1/049, Grant No. 7/1997] for supporting a part
of this work.
Supplemental data
Supplemental data for this article can be accessed 10.1080/095933
30.2014.888097.
References
[1] Khamis M, Karaman R, Qurie M, Abbadi J, Nusseibeh
S, Manassra A, Nir S. Performance of micelle–clay ﬁlters
for removing pollutants and bacteria from tertiary treated
wastewater. J Environ Sci Eng. 2012;1:160–168.
[2] Webb S, Ternes T, Gibert M, Olejniczak K. Indirect human
exposure to pharmaceuticals via drinking water. Toxicol
Lett. 2003;142:157–167.
[3] Meritxell G, Mira P, Damià B. Multi-residue analytical
methods using LC-tandemMS for the determination of phar-
maceuticals in environmental and wastewater samples: a
review. Anal Bioanal Chem. 2006;386:941–952.
[4] KhamisM, Karaman R, Ayyash F, Qtait A, DeebO,Manssra
A. Eﬃciency of advanced membrane wastewater treatment
plant towards removal of aspirin, salicylic acid, paracetamol
and p-aminophenol. J Environ Sci Eng. 2011;5:121–137.
[5] Tyler CR, Routledge EJ. Natural and anthropogenic envi-
ronmental estrogens: the scientiﬁc basis for risk assessment.
Estrogenic eﬀects in ﬁsh in English rivers with evidence of
their causation. Pure Appl Chem. 1998;70:1795–1804.
[6] Johnson AC, Belfroid A, Di Corcia A. Estimating steroid
estrogens inputs into activated sludge treatment works and
observations on their removal from the eﬄuent. Sci Total
Environ. 2000;256:163–173.
[7] Johnson AC, Sumpter JP. Removal of endocrine disrupting
chemicals in activated sludge treatment works. Environ Sci
Technol. 2002;35:4697–4703.
[8] Ternes TA.Occurrence of drugs inGerman sewage treatment
plants and rivers. Water Res. 1998;32:3245–3260.
[9] Jones OAH, Voulvoulis N, Lester JN. Human pharmaceu-
ticals in wastewater treatment processes. Crit Rev Environ
Sci Technol. 2005;35:401–427.
[10] Hirsch R, Ternes TA, Haberer K, Kratz KL. Determina-
tion of beta blockers and b-sympathomimetics in the aquatic
environment. Vom Wasser. 1996;87:263–274.
[11] BendzD,PaxéusNA,GinnTR,LogeFJ.Occurrence and fate
of pharmaceutically active compounds in the environment,
a case study. J Hazard Mater. 2005;122:195–204.
[12] Ohlenbusch G, Kumke MU, Frimmel FH. Sorption of phe-
nols to dissolved organic matter investigated by solid phase
micro extraction. Sci Total Environ. 2000;253:63–74.
[13] Goodman-Hilman A, Rall T, Nier A, Taylor P. The phar-
macological basis of therapeutics. New York: McGraw-Hill;
1996.
[14] Schepers A, Pires Nuno MM, Eefting D, de Vries MR, van
Bockel JH, Quax PHA. Short-term dexamethasone treat-
ment inhibits vein graft thickening in hypercholesterolemic
ApoE3Leiden transgenic mice. J Vasc Surg. 2006;43:
809–815.
[15] Muller DW, Golomb G, Gordon D, Levy RJ. Site-speciﬁc
dexamethasone delivery for the prevention of neointimal
thickening after vascular stent placement. Coron Artery Dis.
1994;5:435–442.
[16] Strecker EP, Gabelmann A, Boos I, Lucas C, Xu Z, Haber-
stroh J, Freudenberg N, Stricker H, Langer M, Betz E.
Eﬀect on intimal hyperplasia of dexamethasone released
from coated metal stents compared with non-coated stents
in canine femoral arteries. Cardiovasc Intervent Radiol.
1998;21:487–496.
[17] Hoﬀmann R, Langenberg R, Radke P, Franke A, Blindt
R, Ortlepp J, Popma JJ, Weber C, Hanrath P. Evaluation
of a high-dose dexamethasone-eluting stent. Am J Cardiol.
2004;94:193–195.
[18] British Pharmacopoeia Commission. British Pharmacopeia.
Revised edition. London: British Pharmacopoeia Commis-
sion; 2007. Q1
[19] Martindale: The Extra Pharmacopoeia. 30th ed. London:
Pharmaceuticals Press; 1993. p. 728.
[20] Mishael YG, Undabeyita T, Rytwo G, Papahadjopoulos-
Sternberg B, Rubin B, Nir S. Sulfometuron adsorp-
tion via alkylammonium cations adsorption as monomers
and micelles on montmorillonite. J Agri Food Chem.
2002;50:2856–2863.
[21] Polubesova T, Nir S, Zadaka D, Rabinovitz O, Serban C,
Groisman L, et al. Water puriﬁcation of organic pollutants
by optimized micelle-clay systems. Environ Sci Technol.
2005;39:2369–2384. Q2
[22] Polubesova T, Zadaka D, Groisman L, Nir S. Water reme-
diation by micelle–clay system: case study for tetracy-
cline and sulfonamide antibiotics. Water Res. 2006;40:
2369–2374.
[23] ZadakaD,MishaelYG, PolubesovaT, SerbanC,Nir S.Mod-
iﬁed silicates and porous glass as adsorbents for removal
of organic pollutants from water and comparison activated
carbons. Appl Clay Sci. 2007;36:174–181.
1121
1122
1123
1124
1125
1126
1127
1128
1129
1130
1131
1132
1133
1134
1135
1136
1137
1138
1139
1140
1141
1142
1143
1144
1145
1146
1147
1148
1149
1150
1151
1152
1153
1154
1155
1156
1157
1158
1159
1160
1161
1162
1163
1164
1165
1166
1167
1168
1169
1170
1171
1172
1173
1174
1175
1176
1177
1178
1179
1180
1181
1182
1183
1184
1185
1186
1187
1188
1189
1190
1191
1192
1193
1194
1195
1196
1197
1198
1199
1200
1201
1202
1203
1204
1205
1206
1207
1208
1209
1210
1211
1212
1213
1214
1215
1216
1217
1218
1219
1220
1221
1222
1223
1224
1225
1226
1227
1228
1229
1230
1231
1232
Environmental Technology 11
[24] Karaman R, Khamis M, Quried M, Halabieh R, Makharzeh
I, Nasser A, Manassra A, Abbadi J, Qtait F, Bufo S,
Nir S. Removal of diclofenac potassium from wastewa-
ter using clay-micelle complex. Environ Technol. 2012;33:
1279–1287.
[25] Khalaf S, Al-Rimawi F, Khamis M, Zimmerman D, Shuali
U, Nir S, Scrano L, Bufo SA, Karaman R. Eﬃciency of
advanced wastewater treatment plant system and laboratory-
scale micelle–clay ﬁltration for the removal of ibuprofen
residues. J Environ Sci Health B. 2013;48:814–821.
[26] American Public Health Association (APHA). Standard
methods for the examination of water and wastewater. 19th
ed. Washington, DC: APHA; 1995.
[27] American Public Health Association (APHA). Standard
methods for the examination of water and wastewater. 21th
ed. Washington, DC: APHA; 2005.
[28] Dakiky M, Khamis M, Manasra A, Mereb M. Selective
adsorption of chromium (VI) in industrial waste water using
low cost abundantly available adsorbents. Adv Environ Res.
2002;6:533–540.
[29] Chen Q, Zielinski D, Chen J, Koski A, Werst D, Nowak
S. A validated, stability-indicating HPLC method for the
determination of dexamethasone related substances on
dexamethasone-coated drug-eluting stents. J Pharm Biomed
Anal. 2008;48:732–738.
[30] Tomlinson ES, Maggs J, Park BK, Back DJ. Dexamethasone
metabolites in vitro: species diﬀerences. J Steroid Biochem
Mol Biol. 1997;4:62–68.
[31] Andreottola G, Bonomo L, Pollice A. Comparison of
batch completely mixed and column tests for the evalua-
tion of phenol mobility in natural soils. Environ Technol.
1997;18:1037–1044.
[32] Qurie M, Khamis M, Malek F, Nir S, Bufo SA, Abbadi J,
Scrano L, KaramanR. Stability and removal of naproxen and
its metabolite by advanced membrane wastewater treatment
plant and micelle–clay complex. CLEAN Soil Air Water.
2013; online. doi:10.1002/clen.201300179.
[33] Wibulswas R, White DA, Rautiu R. Removal of humic sub-
stances from water by alumina-based pillared clays. Environ
Technol. 1998;19:627–632.
[34] Cheknane B, Baudu M, Basly J-Ph, Bouras O. A des-
orption of basic dyes in single and mixture systems on
granular inorganic–organic pillared clays. Environ Technol.
2010;31:815–822.
[35] Chudoba P, Pannier M. Use of powdered clay to
upgrade activated sludge process. EnvironTechnol. 1994;15:
863–870.
[36] WuF-C, TsengR-L, JuangR-S. Kinetics of color removal by
adsorption fromwater using activated clay. EnvironTechnol.
2001;22:721–729.
